argus

Alkem Laboratories Limited

NSE: ALKEMINE540L0101462,293 Cr

Timeline

Time (IST)TypeMEventSrc
26 Aug, 05:23 pmAlkem Laboratories Ltd - 539523 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011bse
20 Aug, 06:01 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
20 Aug, 06:01 pmAlkem Laboratories Limited has informed the Exchange about Q1 FY2027 - Earnings Conference Call Transcriptnse
20 Aug, 06:00 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
17 Aug, 07:02 pmAlkem Laboratories Ltd - 539523 - Shareholder Meeting / Postal Ballot-Outcome of Court Convened Meetingbse
14 Aug, 07:14 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
14 Aug, 07:07 pmAlkem Laboratories Limited has informed the Exchange about Link of Recordingnse
14 Aug, 01:57 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
14 Aug, 01:56 pmAlkem Laboratories Limited has informed the Exchange about Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended ( SEBI LODR Regulations ).nse
14 Aug, 01:55 pmAlkem Laboratories Ltd - 539523 - Announcement Under Reg 30 (LODR)bse
14 Aug, 01:54 pmAlkem Laboratories Limited has informed the Exchange about Investor Presentationnse
14 Aug, 01:53 pmAlkem Laboratories Ltd - 539523 - Results- Unaudited Financial Results For Quarter Ended June 30, 2026bse
14 Aug, 01:48 pmAlkem Laboratories Ltd - 539523 - Board Meeting Outcome for Outcome Of Board Meeting Dated 14/08/2026bse
14 Aug, 01:45 pmAlkem Laboratories Limited has submitted to the Exchange, outcome of the Board Meeting held on 14th August, 2026nse
06 Aug, 04:30 pmAlkem Laboratories Limited has informed the Exchange about Update on US FDA Inspection at Company s manufacturing facility located at Amaliya, Damannse
03 Aug, 05:40 pmAlkem Laboratories Limited has informed the Exchange regarding Appointment of Senior Management Personnelnse
03 Aug, 05:40 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Managementbse
30 Jul, 05:10 pmAlkem Laboratories Limited has informed the Exchange about disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015nse
29 Jul, 08:39 pmAlkem Laboratories Limited has informed the Exchange about Business Responsibility and Sustainability Report for financial year ended 31st March, 2026.nse
29 Jul, 08:34 pmAlkem Laboratories Ltd - 539523 - Reg. 34 (1) Annual Report.bse
23 Jul, 01:22 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Managementbse
23 Jul, 01:22 pmAlkem Laboratories Limited has informed the Exchange regarding Resignation of Dr. Jitendra Singh Huda as Other of the company w.e.f. July 23, 2026.nse
21 Jul, 03:30 pmAlkem Laboratories Ltd - 539523 - Board Meeting Intimation for Notice Of Meeting Of The Board Of Directors Of The Company.bse
17 Jul, 06:07 pmAlkem Laboratories Limited has informed the Exchange about Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended ( SEBI LODR Regulations )- Updates on Acquisition.nse
16 Jul, 02:58 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Acquisitionbse
16 Jul, 02:53 pmAlkem Laboratories Limited has informed the Exchange about Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended ( SEBI LODR Regulations ).nse
15 Jul, 03:39 pmAlkem Laboratories Ltd - 539523 - Notice Convening The Meeting Of The Equity Shareholders Of The Company Pursuant To The Order Of The Hon'Ble National Company Law Tribunal, Mumbai Bench ('NCLT') Dated June 10, 2026 ('Order')bse
01 Jul, 04:57 pmAlkem Laboratories Ltd - 539523 - Disclosure Under Regulation 30 Of SEBI LODRbse
01 Jul, 04:48 pmAlkem Laboratories Limited has informed the Exchange about Action(s) taken or orders passednse
29 Jun, 09:39 amAlkem Laboratories Limited has informed the Exchange about Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended ( SEBI LODR Regulations )- Updates on Acquisitionnse
03 Jun, 05:36 pmAlkem Laboratories Ltd - 539523 - Dislcosure letter under Regulation 11(5) of The Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.bse
02 Jun, 03:17 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
02 Jun, 03:13 pmAlkem Laboratories Limited has informed the Exchange regarding a press release dated Jun 02, 2026, titled "Alkem Laboratories Limited becomes first in India to launch semaglutide in single-shot pre-filled syringes at price starting INR350.".nse
01 Jun, 04:37 pmAlkem Laboratories Limited has informed the Exchange about Transcriptnse
01 Jun, 04:27 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
29 May, 11:23 amAlkem Laboratories Ltd - 539523 - Compliances-Reg.24(A)-Annual Secretarial Compliancebse
28 May, 06:38 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
28 May, 06:29 pmAlkem Laboratories Limited has informed the Exchange about Link of Recordingnse
28 May, 01:41 pmAlkem Laboratories Limited has informed the Exchange about Investor Presentationnse
28 May, 01:39 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
28 May, 01:39 pmAlkem Laboratories Limited has informed the Exchange regarding Intimation for Cutoff date for the purpose of the Annual General Meeting.nse
28 May, 01:37 pmAlkem Laboratories Ltd - 539523 - Corporate Action - Fixes Record Date For Payment Of Dividend And Cut Off For AGMbse
28 May, 01:34 pmAlkem Laboratories Limited has informed the Exchange that Record date for the purpose of Dividend is 07-Aug-2026.nse
28 May, 01:34 pmAlkem Laboratories Ltd - 539523 - Corporate Action-Board approves Dividendbse
28 May, 01:32 pmAlkem Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 28, 2026, recommended Final Dividend of Rs. 10 per equity share.nse
28 May, 01:32 pmAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Directoratebse
28 May, 01:30 pmAlkem Laboratories Ltd - 539523 - Results- Audited Financials Results For The Quarter And Year Ended 31St March 26bse
28 May, 01:28 pmAlkem Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company.nse
28 May, 01:25 pmAlkem Laboratories Limited has submitted to the Exchange, Outcome of the Board Meeting held on 28th May, 2026nse
28 May, 01:24 pmAlkem Laboratories Ltd - 539523 - Board Meeting Outcome for Please Find Enclosed Herewith The Outcome Of The Board Meeting Dated 28Th May, 26bse